XERS - Why Xeris Biopharma Shares Are Trading Higher Today | Benzinga
Xeris Biopharma Holdings Inc (NASDAQ: XERS) shares are trading higher by around 9% after the company revised its FY23 outlook.
The company raised the lower end of its revenue guidance, revising the range to $155 million-$165 million (vs. consensus of $158.2 million) from $145 million-$165 million.
Also, the company raised cash, cash equivalents, and short-term investment outlook to $65 million-$70 million (from $55 million-$65 million), suggesting a net cash outflow of about $11 ...